radium Ra 224-labeled calcium carbonate microparticles
Term · Oncology and biomedicine · MLC-T-ONC-016345
A radiopharmaceutical composed of biodegradable calcium carbonate microspheres labeled with the alpha-emitting radioisotope radium Ra 224, with antineoplastic activity. Upon intraperitoneal (IP) administration of the radium Ra 224-labeled calcium carbonate microparticles, Ra 224 kills tumor cells through local emission of high energy alpha particles, causing DNA double-strand breaks. The short range effects of alpha emission allows for localized DNA damage with limited toxicity to nearby healthy tissue.
| Identifier | MLC-T-ONC-016345 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 224Ra-labeled calcium carbonate micro-particles; alpha-emitting 224Ra calcium carbonate microspheres; Ra-224 alpha-emitting calcium carbonate microparticles |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016345",
"term": "radium Ra 224-labeled calcium carbonate microparticles",
"field": "Oncology and biomedicine",
"definition": "A radiopharmaceutical composed of biodegradable calcium carbonate microspheres labeled with the alpha-emitting radioisotope radium Ra 224, with antineoplastic activity. Upon intraperitoneal (IP) administration of the radium Ra 224-labeled calcium carbonate microparticles, Ra 224 kills tumor cells through local emission of high energy alpha particles, causing DNA double-strand breaks. The short range effects of alpha emission allows for localized DNA damage with limited toxicity to nearby healthy tissue.",
"synonyms": [
"224Ra-labeled calcium carbonate micro-particles",
"alpha-emitting 224Ra calcium carbonate microspheres",
"Ra-224 alpha-emitting calcium carbonate microparticles"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/radium-ra-224-labeled-calcium-carbonate-microparticles/"
}
Record 14,039 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.